Foundation Medicine

When Summer was diagnosed with stage IV lung cancer, #biomarker #testing provided answers and options that equipped her and her medical team with a treatment plan. More resources and information on Foundation Medicine and biomarker testing: spkl.io/6016AGv3n

Visit our Precision Points blog to explore the latest on recent advances in precision medicine and the resources available to ensure patients can access high-quality tests that can help inform their treatment. 🔬 Click here to explore: foundationmedicine.com/blog?utm_sourc…

#NewResearch in @OncJournal: “Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancer.” Click here for the full publication: spkl.io/6011AE45U

July is UV Awareness Month, a time dedicated to share resources and education around the dangers of ultraviolet (UV) radiation. UV exposure involves risks, including sunburns and skin cancer. Read our post for some key facts.

#NewResearch in @Nature_NPJ precision oncology: “Tissue-based genomic profiling of 300,000 tumors highlights the detection of variants with low allele fraction.” Explore the publication here: spkl.io/6015ABS9H

We’re still thinking back about our time at #ASCO25! The meeting always provides some time to reflect upon and learn more about the latest advancements in oncology. We asked some of our team members what gives them hope about the future of cancer care. Hear what they had to say.

Utilizing Foundation Medicine’s tissue-free treatment response monitoring assay, new #research demonstrated the clinical value of treatment response monitoring by ctDNA in real-world patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

This year, Foundation Medicine celebrates our 15th anniversary. Look back at the milestones we’ve achieved in a new blog from our CEO Dan Malarek: foundationmedicine.com/blog/15-year-a…

Honored to have joined the oncology community and to have been part of #ASCO25. Our team had so many great interactions and conversations last week in Chicago. #WeAreFMI #MissNotOne

New research being presented at #ASCO25 showcases new innovations in #BreastCancer treatment and care. Hear some quick highlights from Dr. Julia Quintanilha, Senior Scientist at Foundation Medicine. Learn more: spkl.io/6016ffeTQ

New study at #ASCO25 analyzes the genomic landscape of NPM1 genomic alterations in acute myeloid leukemia. Find out more and meet with our team – Booth 27021: spkl.io/6018fferC

Learn more about the latest in non-small cell #LungCancer (NSCLC) with two new presentations at #ASCO25. Connect with us at booth 27021: spkl.io/6015ffeRJ

We’re in Chicago for #ASCO25 – come visit us at booth 27021 to learn more about Foundation Medicine. Schedule a meeting with us today: spkl.io/6014ffdmC #MissNotOne

Two pieces of research at #ASCO25 feature new data on the detection of clonal hematopoiesis in #PancreaticCancer and #OvarianCancer using liquid biopsies. Discover more & connect with our team – Booth 27021: spkl.io/6010ffdYC

Connect with Foundation Medicine in Chicago! Stop by Booth 27021 to learn more about our high-quality tests and work in precision cancer care: spkl.io/6012ffroj #ASCO25

Announcing our new, expanded immunohistochemistry (IHC) test offerings to include MET IHC testing as an add-on to Foundation Medicine’s comprehensive genomic profiling (CGP) test orders for patients with non-squamous non-small cell lung cancer: spkl.io/6019fNZQz